Page last updated: 2024-09-03

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and kainic acid

n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with kainic acid in 1 studies

Compound Research Comparison

Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Recent Studies (post-2010)
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
Studies
(kainic acid)
Trials
(kainic acid)
Recent Studies (post-2010) (kainic acid)
791169,54031,775

Protein Interaction Comparison

ProteinTaxonomyn-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)kainic acid (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 2Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 3Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 4Rattus norvegicus (Norway rat)4.2857
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 4Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)0.0126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1

Other Studies

1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and kainic acid

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012